FDA Requires New Opioid Label Warnings Over Risks Of Suddenly Stopping Treatment
The FDA is requiring opioids to carry new label warning about the risks of sudden discontinuation, which can lead to withdrawal symptoms, pain and suicide.…
«
»
The FDA is requiring opioids to carry new label warning about the risks of sudden discontinuation, which can lead to withdrawal symptoms, pain and suicide.…
The FDA is holding a workshop next month on strategies to ween teens off of tobacco and nicotine addictions.…
A new study indicates buprenorphine is likely the best treatment for neonatal abstinence syndrome, but warns that there’s too little data and more studies need to be done.…
The FDA is calling for medical device manufacturers to develop devices designed to prevent, treat or diagnose opioid addiction.…
Millions of Americans may be addicted to antidepressants, which have been linked to severe withdrawal symptoms which make them very hard to quit, according to new reports.…